Archemix, Dicerna in RNAi deal

Archemix Corp. (Cambridge, Mass.) and Dicerna Pharmaceuticals Inc. (Watertown, Mass.) partnered to develop conjugated aptamer-dicer substrate RNAi (DsiRNA) therapeutics. The companies will combine Arc...